Skip to main content
logo
XPO, Inc. (XPO)
NYSE: XPO · Real-Time Price · USD
130.31
+3.77 (2.98%)
Aug 13, 2025, 4:00 PM - Market closed

Theseus Pharmaceuticals Revenue

XPO, Inc. had revenue of $2.08B in the quarter ending June 30, 2025, with 0.05% growth. This brings the company's revenue in the last twelve months to $8.01B, down -0.10% year-over-year. In the year 2024, XPO, Inc. had annual revenue of $8.07B with 4.24% growth.

Revenue (ttm)
$8.01B
Revenue Growth
-0.10%
P/S Ratio
1.90
Revenue / Employee
$210,763
Employees
38,000
Market Cap
15.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.07B328.00M4.24%
Dec 31, 20237.74B26.00M0.34%
Dec 31, 20227.72B516.00M7.16%
Dec 31, 20217.20B1.03B16.76%
Dec 31, 20206.17B-4.51B-42.25%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RTX Corporation83.60B
The Boeing Company75.33B
Lockheed Martin71.84B
Caterpillar63.14B
Deere & Company45.38B
General Electric Company41.61B
Honeywell International39.99B
GE Vernova36.62B
Revenue Rankings

XPO News

More News